Skip to main content
SpringerLink
Log in

Onychomycosis

  • Chapter
  • First Online:
European Handbook of Dermatological Treatments

  • 22 Accesses

Abstract

Onychomycosis is the most common nail disorder. It is caused by dermatophytes, yeasts, and non-dermatophyte molds and is more common in immunosuppressed and patients with nail trauma. Treatment of choice should be individualized and should take into account the type of fungi isolated through direct microscopy and culture, the age of the patient, and concomitant use of other systemic medications. Topical treatment is recommended for restricted disease. The mainstay of therapy consists of 8% ciclopirox and 5% amorolfine nail lacquers. Systemic treatment is recommended in extensive disease. Commonly prescribed agents include terbinafine, itraconazole, and fluconazole. Treatment through the use of devices includes lasers and photodynamic therapy. Chemical or surgical nail avulsion should be used in combination with topical or systemic treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 349.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 449.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Alley MR, Baker SJ, Beutner KR, Plattner J. Recent progress on the topical therapy of onychomycosis. Expert Opin Investig Drugs. 2007;16:157–67.

    Article  CAS  PubMed  Google Scholar 

  • Amichai B, Nitzan B, Mosckovitz R, et al. Iontophoretic delivery of terbinafine in onychomycosis: a preliminary study. Br J Dermatol. 2010;162:46–50.

    Article  CAS  PubMed  Google Scholar 

  • Banerjee M, Ghosh AK, Basak S, Das KD, Gangopadhyay DN. Comparative evaluation of effectivity and safety of topical amorolfine and clotrimazole in the treatment of tinea corporis. Indian J Dermatol. 2011;56:657–62.

    Article  PubMed  PubMed Central  Google Scholar 

  • Baran R, Hay R, Perrin C. Superficial white onychomycosis revisited. J Eur Acad Dermatol Venereol. 2004;18:569–71.

    Article  CAS  PubMed  Google Scholar 

  • Baran R, Hay R, Haneke E, Tosti A, editors. Onychomycosis: the current approach to diagnosis and therapy. London: Informa Healthcare; 2006.

    Google Scholar 

  • Belyayeva E, Gregoriou S, Chalikias J, et al. The impact of nail disorders on quality of life. Eur J Dermatol. 2013;23:366–71.

    Article  PubMed  Google Scholar 

  • Bentley-Phillips B. The treatment of onychomycosis with miconazole tincture. S Afr Med J. 1982;62(2):57–8.

    CAS  PubMed  Google Scholar 

  • Bontems O, Hauser PM, Monod M. Evaluation of a polymerase chain reaction-restriction fragment length polymorphism assay for dermatophyte and nondermatophyte identification in onychomycosis. Br J Dermatol. 2009;161:791–6.

    Article  CAS  PubMed  Google Scholar 

  • Di Chiacchio N, Suarez MV, Madeira CL, Loureiro WR. An observational and descriptive study of the epidemiology of and therapeutic approach to onychomycosis in dermatology offices in Brazil. An Bras Dermatol. 2013;88(Suppl 1):3–11.

    PubMed  Google Scholar 

  • Elewski B, Pollak R, Ashton S, Rich P, Schlessinger J, Tavakkol A. A randomized, placebo- and active-controlled, parallel-group, multicentre, investigator-blinded study of four treatment regimens of posaconazole in adults with toenail onychomycosis. Br J Dermatol. 2012;166:389–98.

    Article  CAS  PubMed  Google Scholar 

  • Elewski BE, Rich P, Pollak R, Pariser DM, Watanabe S, Senda H, Ieda C, Smith K, Pillai R, Ramakrishna T, Olin JT. Efinaconazole 10% solution in the treatment of toenail onychomycosis: two phase III multicenter, randomized, double-blind studies. J Am Acad Dermatol. 2013;68:600–8.

    Article  CAS  PubMed  Google Scholar 

  • Gilaberte Y, Aspiroz C, Martes MP, et al. Treatment of refractory fingernail onychomycosis caused by nondermatophyte molds with methylaminolevulinate photodynamic therapy. J Am Acad Dermatol. 2011;65:669–71.

    Article  PubMed  Google Scholar 

  • Grover C, Bansal S, Nanda S, Reddy BS, Kumar V. Combination of surgical avulsion and topical therapy for single nail onychomycosis: a randomized controlled trial. Br J Dermatol. 2007;157:364–8.

    Article  CAS  PubMed  Google Scholar 

  • Gupta AK, Ryder JE. The use of oral antifungal agents to treat onychomycosis. Dermatol Clin. 2003;21:469–79.

    Article  CAS  PubMed  Google Scholar 

  • Gupta A, Simpson F. Device-based therapies for onychomycosis treatment. Skin Therapy Lett. 2012;17:4–9.

    CAS  PubMed  Google Scholar 

  • Gupta AK, Chang P, Del Rosso JQ, Adam P, Hofstader SL. Onychomycosis in children: prevalence and management. Pediatr Dermatol. 1998;15:464–71.

    Article  CAS  PubMed  Google Scholar 

  • Gupta AK, Fleckman P, Baran R. Ciclopirox nail lacquer topical solution 8% in the treatment of toenail onychomycosis. J Am Acad Dermatol. 2000;43:S70–80.

    Article  CAS  PubMed  Google Scholar 

  • Gupta AK, Ryder JE, Johnson AM. Cumulative meta-analysis of systemic antifungal agents for the treatment of onychomycosis. Br J Dermatol. 2004;150:537–44.

    Article  CAS  PubMed  Google Scholar 

  • Gupta AK, Lynch LE, Kogan N, Cooper EA. The use of an intermittent terbinafine regimen for the treatment of dermatophyte toenail onychomycosis. J Eur Acad Dermatol Venereol. 2009;23:256–62.

    Article  CAS  PubMed  Google Scholar 

  • Hay RJ, Mackie RM, Clayton YM. Tioconazole nail solution–an open study of its efficacy in onychomycosis. Clin Exp Dermatol. 1985;10:111–5.

    Article  CAS  PubMed  Google Scholar 

  • Kozarev J, Vizintin Z. Novel laser therapy in treatment of onychomycosis. J Laser Health Acad. 2010;1:1–8.

    Google Scholar 

  • Landsman AS, Robbins AH, Angelini PF, et al. Treatment of mild, moderate, and severe onychomycosis using 870- and 930-nm light exposure. J Am Podiatr Med Assoc. 2010;100:166–77.

    Article  PubMed  Google Scholar 

  • Lecha M, Effendy I, Feuilhade de Chauvin M, Di Chiacchio N, Baran R. Task force on onychomycosis education. J Eur Acad Dermatol Venereol. 2005;19(Suppl 1):25–33.

    Article  PubMed  Google Scholar 

  • Lurati M, Baudraz-Rosselet F, Vernez M, Spring P, Bontems O, Fratti M, Monod M. Efficacious treatment of non-dermatophyte mould onychomycosis with topical amphotericin B. Dermatology. 2011;223:289–92.

    Article  CAS  PubMed  Google Scholar 

  • Malay DS, Yi S, Borowsky P, Downey MS, Mlodzienski AJ. Efficacy of debridement alone versus debridement combined with topical antifungal nail lacquer for the treatment of pedal onychomycosis: a randomized, controlled trial. J Ankle Foot Surg. 2009;48:294–308.

    Article  Google Scholar 

  • Monti D, Saccomani L, Chetoni P, Burgalassi S, Tampucci S, Mailland F. Validation of bovine hoof slices as a model for infected human toenails: in vitro ciclopirox transungual permeation. Br J Dermatol. 2011;165:99–105.

    Article  CAS  PubMed  Google Scholar 

  • Piraccini BM, Rech G, Tosti A. Photodynamic therapy of onychomycosis caused by trichophyton rubrum. J Am Acad Dermatol. 2008;59:S75–6.

    Article  PubMed  Google Scholar 

  • Rigopoulos D, Larios G, Gregoriou S, Alevizos A. Acute and chronic paronychia. Am Fam Physician. 2008;77:339–46.

    PubMed  Google Scholar 

  • Roberts DT, Taylor WD, Boyle J, British Association of Dermatologists. Guidelines for treatment of onychomycosis. Br J Dermatol. 2003;148:402–10.

    Article  CAS  PubMed  Google Scholar 

  • Sehgal VN, Srivastava G, Dogra S, Chaudhary A, Adhikari T. Onychomycosis: an Asian perspective. Skinmed. 2010;8:37–45.

    PubMed  Google Scholar 

  • Sigurgeirsson B, Ghannoum M. Therapeutic potential of TDT 067 (terbinafine in Transfersome): a carrier-based dosage form of terbinafine for onychomycosis. Expert Opin Investig Drugs. 2012;21:1549–62.

    Article  CAS  PubMed  Google Scholar 

  • Sigurgeirsson B, Billstein S, Rantanen T, Ruzicka T, di Fonzo E, Vermeer BJ, et al. L.I.O.N. study: efficacy and tolerability of continuous terbinafine (Lamisil) compared to intermittent itraconazole in the treatment of toenail onychomycosis. Lamisil vs. itraconazole in onychomycosis. Br J Dermatol. 1999;141(Suppl 56):5–14.

    Article  PubMed  Google Scholar 

  • Sigurgeirsson B, Olafsson JH, Steinsson JT, Kerrouche N, Sidou F. Efficacy of amorolfine nail lacquer for the prophylaxis of onychomycosis over 3 years. J Eur Acad Dermatol Venereol. 2010;24:910–5.

    Article  CAS  PubMed  Google Scholar 

  • Singal A, Khanna D. Onychomycosis: diagnosis and management. Indian J Dermatol Venereol Leprol. 2011;77:659–72.

    Article  PubMed  Google Scholar 

  • Sobue S, Sekiguchi K. Difference in percutaneous absorption and intracutaneous distribution in Guinea pigs among topical antifungal drugs (tioconazole solution, tioconazole cream, miconazole nitrate solution and bifonazole solution). Biol Pharm Bull. 2004;27:1428–32.

    Article  CAS  PubMed  Google Scholar 

  • Sotiriou E, Koussidou-Eremonti T, Chaidemenos G, et al. Photodynamic therapy for distal and lateral subungual toenail onychomycosis caused by trichophyton rubrum: preliminary results of a single-Centre open trial. Acta Derm Venereol. 2010;90:216–7.

    Article  PubMed  Google Scholar 

  • Spriet I, Lambrecht C, Lagrou K, Verhamme B. Successful eradication of Scytalidium dimidiatum-induced ungual and cutaneous infection with voriconazole. Eur J Dermatol. 2012;22(2):197–9.

    Article  CAS  PubMed  Google Scholar 

  • Subissi A, Monti D, Togni G, Mailland F. Ciclopirox: recent nonclinical and clinical data relevant to its use as a topical antimycotic agent. Drugs. 2010;70:2133–52.

    Article  PubMed  Google Scholar 

  • Tosti A, Piraccini BM, Lorenzi S. Onychomycosis caused by nondermatophytic molds: clinical features and response to treatment of 59 cases. J Am Acad Dermatol. 2000;42:217–24.

    Article  CAS  PubMed  Google Scholar 

  • Tsuboi R, Unno K, Komatsuzaki H, Ogawa H, Kasai T, Oka K, Takiuchi I, Kitamura K, Higashi N, Nakashima Y, Nishimoto K. Topical treatment of onychomycosis by occlusive dressing using bifonazole cream containing 40% urea. Nihon Ishinkin Zasshi. 1998;39:11–6.

    Article  CAS  Google Scholar 

  • van de Kerkhof PC, Pasch MC, Scher RK, Kerscher M, Gieler U, Haneke E, Fleckman P. Brittle nail syndrome: a pathogenesis-based approach with a proposed grading system. J Am Acad Dermatol. 2005;53:644–51.

    Article  PubMed  Google Scholar 

  • Watanabe D, Kawamura C, Masuda Y, et al. Successful treatment of toenail onychomycosis with photodynamic therapy. Arch Dermatol. 2008;144:19–21.

    Article  PubMed  Google Scholar 

  • Zhou ZL, Zhang JP, Wang XM, Shao Q, Hu JY, Han QD. Compliance of the patients and related influential factors on the topical antifungal treatment of onychomycosis. Zhonghua Liu Xing Bing Xue Za Zhi. 2011;32:720–3.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. 1nd Department of Dermatology, University of Athens Medical School, Andreas Sygros Hospital, Athens, Greece

    Dimitris Rigopoulos & Stamatis Gregoriou

Authors
  1. Dimitris Rigopoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stamatis Gregoriou
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dimitris Rigopoulos .

Editor information

Editors and Affiliations

  1. Andreas Syggros Hospital, Athens State University, Athens, Greece

    Andreas D. Katsambas

  2. Research Center CSRMR, Marconi University, Rome, Roma, Italy

    Torello M. Lotti

  3. Andreas Syggros Hospital, Athens State University, Athens, Greece

    Clio Dessinioti

  4. Dermatoloy Unit, Livorno Hospital, Livorno, Italy

    Angelo Massimiliano D'Erme

Rights and permissions

Reprints and permissions

Copyright information

© 2023 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Rigopoulos, D., Gregoriou, S. (2023). Onychomycosis. In: Katsambas, A.D., Lotti, T.M., Dessinioti, C., D'Erme, A.M. (eds) European Handbook of Dermatological Treatments. Springer, Cham. https://doi.org/10.1007/978-3-031-15130-9_66

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-15130-9_66

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-15129-3

  • Online ISBN: 978-3-031-15130-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation